Literature DB >> 6710731

BCG in the management of superficial bladder cancer.

S A Brosman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6710731     DOI： 10.1016/s0090-4295(84)80074-6

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  5 in total

1.  Evaluation of a low-dose intravesical bacillus Calmette-Guérin (Tokyo strain) therapy for superficial bladder cancer.

Authors:  M Takashi; K Wakai; Y Ohno; T Murase; K Miyake
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

2.  Synchronous RCC and TCC of the Kidney in a Patient With Multiple Recurrent Bladder Tumors.

Authors:  K Michel; A Belldegrun
Journal:  Rev Urol       Date:  1999

Review 3.  The use of botulinum neurotoxin type a in a patient with refractory urge incontinence to facilitate the intravesical treatment of bladder carcinoma.

Authors:  Mina Fam; Patricia Gilhooly
Journal:  Rev Urol       Date:  2014

4.  Combined therapeutic effects of an immunomodulator, PSK, and chemotherapy with carboquone on rat bladder carcinoma.

Authors:  D D Mickey
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  Total cystectomy after intravesical bacillus Calmette-Guérin (Tokyo strain) therapy for superficial bladder cancer: experience in Japan.

Authors:  M Takashi; A Kondo; Y Nakano; Y Takagi; T Sakata; K Miyake
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.